TITLE

Chronic cutaneous leishmaniasis mimicking sebopsoriasis

AUTHOR(S)
Schepis, Carmelo; Siragusa, Maddalena; Alberti, Antonino; Palazzo, Rosaria
PUB. DATE
June 1998
SOURCE
Acta Dermato-Venereologica;6/1/1998, Vol. 78 Issue 3, p231
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Focuses on the mimicking of chronic cutaneous leishmaniasis on sebopsoriasis. Lack of improvement from topical and systemic therapy for sebopsoriasis; Manifestation of leishmaniasis with different clinical expressions; Influence by an isomorphic type reaction.
ACCESSION #
4318206

 

Related Articles

  • COMPARISON BETWEEN THE EFFICACY OF PHOTODYNAMIC THERAPY AND TOPICAL PAROMOMYCIN IN THE TREATMENT OF OLD WORLD CUTANEOUS LEISHMANIASIS: A PLACEBO-CONTROLLED, RANDOMIZED CLINICAL TRIAL. Asilian, Ali; Davami, Majid // Indian Journal of Dermatology;2006, Vol. 51 Issue 3, p182 

    Background: The optimal treatment for cutaneous leishmaniasis (CL) is not known. Topical paromomycin is one of the many drugs that have been suggested for the treatment of CL caused by Leishmania major. Recently, topical photodynamic therapy (PDT) has been reported to be effective in the...

  • Pathogen- and Host-Directed Antileishmanial Effects Mediated by Polyhexanide (PHMB). Firdessa, Rebuma; Good, Liam; Amstalden, Maria Cecilia; Chindera, Kantaraja; Kamaruzzaman, Nor Fadhilah; Schultheis, Martina; Röger, Bianca; Hecht, Nina; Oelschlaeger, Tobias A.; Meinel, Lorenz; Lühmann, Tessa; Moll, Heidrun // PLoS Neglected Tropical Diseases;10/2/2015, Vol. 9 Issue 10, p1 

    Background: Cutaneous leishmaniasis (CL) is a neglected tropical disease caused by protozoan parasites of the genus Leishmania. CL causes enormous suffering in many countries worldwide. There is no licensed vaccine against CL, and the chemotherapy options show limited efficacy and high...

  • Imported Mucosal Leishmaniasis in a Traveler. Scope, A.; Trau, H.; Bakon, M.; Yarom, N.; Nasereddin, A.; Schwartz, E. // Clinical Infectious Diseases;9/15/2003, Vol. 37 Issue 6, pe83 

    Describes a case of mucosal leishmaniasis in a traveler returning from South America. Development of nasal symptoms two months after the appearance of cutaneous ulcers; Diagnosis of mucosal Leishmania viannia braziliensis infection five years later; Need to include mucosal leishmaniasis as...

  • The International Dermato-Epidemiology Association (IDEA) Congress Nottingham 2008.  // Journal of Investigative Dermatology;Oct2008, Vol. 128 Issue 10, p2547 

    The article presents several abstracts on dermatology which include relation between objective and subjective itch, the relation of cardiovascular and antidiabetic drugs to psoriasis, and disease-specific instrument for the evaluation of quality of life in patients with cutaneous leishmaniasis.

  • Epidemiological study of reservoir hosts in an endemic area of zoonotic cutaneous leishmaniasis... Yaghoobi-Ershadi, M.R.; Javadian, E. // Bulletin of the World Health Organization;1996, Vol. 74 Issue 6, p587 

    Determines the ecology of natural reservoir hosts of leishmaniasis for possible field trials of leishmania vaccine in the central part of Islamic Republic of Iran. Different reservoir hosts; Varying rates of infection in different villages; Role of rodents; Recommendation of implementing...

  • Current status of cutaneous leishmaniasis in Aleppo, Syrian Arab Republic. Douba, M.; Mowakeh, A. // Bulletin of the World Health Organization;1997, Vol. 75 Issue 3, p253 

    Presents information on a survey carried out on patients who had cutaneous leishmaniasis, Aleppo, Syrian Arab Republic. Examination of the results of the survey carried out; Information on the classes of persons who were unresponsive to the treatment; What resulted with a histopathological...

  • Intravenous sodium stibogluconate may be effective treatment for Old World cutaneous leishmaniasis. Lewis, Jay // Infectious Disease News;Dec2009, Vol. 22 Issue 12, p29 

    The article discusses research on the potential benefit of intravenous sodium stibogluconate in American military personnel with Old World cutaneous leishmaniasias, according to a study presented at the American Society of Tropical Medicine and Hygiene meeting held in Washington, D.C. from...

  • Fluconazole for the Treatment of Cutaneous Leishmaniasis. Zvulunov, Alex; Klaus, Sidney; Vardy, Daniel // New England Journal of Medicine;8/1/2002, Vol. 347 Issue 5, p370 

    A letter to the editor is presented in response to a study on the efficacy of systemic fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major by researcher Abdulrahman A. Alrajhi and colleagues in the March 21, 2002 issue.

  • Fluconazole for the Treatment of Cutaneous Leishmaniasis. Alrajhi, Abdulrahman A.; De Vol, Edward B.; Maguire, James H. // New England Journal of Medicine;8/1/2002, Vol. 347 Issue 5, p370 

    A response from researcher Abdulrahman A. Alrajhi and his colleagues to a letter to the editor about their article on the efficacy of systemic fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major in the March 21, 2002 issue is presented.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics